Protein Bound Paclitaxel (Abraxane) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511246690

Publication Date:

November 8, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Protein Bound Paclitaxel (Abraxane) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Protein Bound Paclitaxel (Abraxane) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Protein Bound Paclitaxel (Abraxane) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Protein Bound Paclitaxel (Abraxane) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Protein Bound Paclitaxel (Abraxane) include Qilu Pharm, Shijiazhuang Pharmaceutical, Celgene, Abraxis Pharmaceutical, Hengrui Medicine, Kelun Pharmaceutical, BeiGene, Yangtze River Pharm and Hisun Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Protein Bound Paclitaxel (Abraxane), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Protein Bound Paclitaxel (Abraxane) by region & country, by Type, and by Application.
The Protein Bound Paclitaxel (Abraxane) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Bound Paclitaxel (Abraxane).
Market Segmentation
By Company
Qilu Pharm
Shijiazhuang Pharmaceutical
Celgene
Abraxis Pharmaceutical
Hengrui Medicine
Kelun Pharmaceutical
BeiGene
Yangtze River Pharm
Hisun Pharmaceutical
Segment by Type:
Prescription Drugs
Over-the-counter Drugs
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Protein Bound Paclitaxel (Abraxane) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Protein Bound Paclitaxel (Abraxane) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Protein Bound Paclitaxel (Abraxane) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Protein Bound Paclitaxel (Abraxane) Product Introduction
1.2 Global Protein Bound Paclitaxel (Abraxane) Market Size Forecast
1.2.1 Global Protein Bound Paclitaxel (Abraxane) Sales Value (2019-2030)
1.2.2 Global Protein Bound Paclitaxel (Abraxane) Sales Volume (2019-2030)
1.2.3 Global Protein Bound Paclitaxel (Abraxane) Sales Price (2019-2030)
1.3 Protein Bound Paclitaxel (Abraxane) Market Trends & Drivers
1.3.1 Protein Bound Paclitaxel (Abraxane) Industry Trends
1.3.2 Protein Bound Paclitaxel (Abraxane) Market Drivers & Opportunity
1.3.3 Protein Bound Paclitaxel (Abraxane) Market Challenges
1.3.4 Protein Bound Paclitaxel (Abraxane) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Protein Bound Paclitaxel (Abraxane) Players Revenue Ranking (2023)
2.2 Global Protein Bound Paclitaxel (Abraxane) Revenue by Company (2019-2024)
2.3 Global Protein Bound Paclitaxel (Abraxane) Players Sales Volume Ranking (2023)
2.4 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Company Players (2019-2024)
2.5 Global Protein Bound Paclitaxel (Abraxane) Average Price by Company (2019-2024)
2.6 Key Manufacturers Protein Bound Paclitaxel (Abraxane) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Protein Bound Paclitaxel (Abraxane) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Protein Bound Paclitaxel (Abraxane)
2.9 Protein Bound Paclitaxel (Abraxane) Market Competitive Analysis
2.9.1 Protein Bound Paclitaxel (Abraxane) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Protein Bound Paclitaxel (Abraxane) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Bound Paclitaxel (Abraxane) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prescription Drugs
3.1.2 Over-the-counter Drugs
3.2 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Type
3.2.1 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Protein Bound Paclitaxel (Abraxane) Sales Value, by Type (2019-2030)
3.2.3 Global Protein Bound Paclitaxel (Abraxane) Sales Value, by Type (%) (2019-2030)
3.3 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Type
3.3.1 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Protein Bound Paclitaxel (Abraxane) Sales Volume, by Type (2019-2030)
3.3.3 Global Protein Bound Paclitaxel (Abraxane) Sales Volume, by Type (%) (2019-2030)
3.4 Global Protein Bound Paclitaxel (Abraxane) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ovarian Cancer
4.1.2 Cervical Cancer
4.1.3 Breast Cancer
4.1.4 Other
4.2 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Application
4.2.1 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Protein Bound Paclitaxel (Abraxane) Sales Value, by Application (2019-2030)
4.2.3 Global Protein Bound Paclitaxel (Abraxane) Sales Value, by Application (%) (2019-2030)
4.3 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Application
4.3.1 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Protein Bound Paclitaxel (Abraxane) Sales Volume, by Application (2019-2030)
4.3.3 Global Protein Bound Paclitaxel (Abraxane) Sales Volume, by Application (%) (2019-2030)
4.4 Global Protein Bound Paclitaxel (Abraxane) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Region
5.1.1 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Region (2019-2024)
5.1.3 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Region (2025-2030)
5.1.4 Global Protein Bound Paclitaxel (Abraxane) Sales Value by Region (%), (2019-2030)
5.2 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Region
5.2.1 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Region (2019-2024)
5.2.3 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Region (2025-2030)
5.2.4 Global Protein Bound Paclitaxel (Abraxane) Sales Volume by Region (%), (2019-2030)
5.3 Global Protein Bound Paclitaxel (Abraxane) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
5.4.2 North America Protein Bound Paclitaxel (Abraxane) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
5.5.2 Europe Protein Bound Paclitaxel (Abraxane) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
5.6.2 Asia Pacific Protein Bound Paclitaxel (Abraxane) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
5.7.2 South America Protein Bound Paclitaxel (Abraxane) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
5.8.2 Middle East & Africa Protein Bound Paclitaxel (Abraxane) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Protein Bound Paclitaxel (Abraxane) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Protein Bound Paclitaxel (Abraxane) Sales Value
6.2.1 Key Countries/Regions Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Protein Bound Paclitaxel (Abraxane) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.3.2 United States Protein Bound Paclitaxel (Abraxane) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Protein Bound Paclitaxel (Abraxane) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.4.2 Europe Protein Bound Paclitaxel (Abraxane) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Protein Bound Paclitaxel (Abraxane) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.5.2 China Protein Bound Paclitaxel (Abraxane) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Protein Bound Paclitaxel (Abraxane) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.6.2 Japan Protein Bound Paclitaxel (Abraxane) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Protein Bound Paclitaxel (Abraxane) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.7.2 South Korea Protein Bound Paclitaxel (Abraxane) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Protein Bound Paclitaxel (Abraxane) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.8.2 Southeast Asia Protein Bound Paclitaxel (Abraxane) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Protein Bound Paclitaxel (Abraxane) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Protein Bound Paclitaxel (Abraxane) Sales Value, 2019-2030
6.9.2 India Protein Bound Paclitaxel (Abraxane) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Protein Bound Paclitaxel (Abraxane) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Qilu Pharm
7.1.1 Qilu Pharm Company Information
7.1.2 Qilu Pharm Introduction and Business Overview
7.1.3 Qilu Pharm Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Qilu Pharm Protein Bound Paclitaxel (Abraxane) Product Offerings
7.1.5 Qilu Pharm Recent Development
7.2 Shijiazhuang Pharmaceutical
7.2.1 Shijiazhuang Pharmaceutical Company Information
7.2.2 Shijiazhuang Pharmaceutical Introduction and Business Overview
7.2.3 Shijiazhuang Pharmaceutical Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Shijiazhuang Pharmaceutical Protein Bound Paclitaxel (Abraxane) Product Offerings
7.2.5 Shijiazhuang Pharmaceutical Recent Development
7.3 Celgene
7.3.1 Celgene Company Information
7.3.2 Celgene Introduction and Business Overview
7.3.3 Celgene Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Celgene Protein Bound Paclitaxel (Abraxane) Product Offerings
7.3.5 Celgene Recent Development
7.4 Abraxis Pharmaceutical
7.4.1 Abraxis Pharmaceutical Company Information
7.4.2 Abraxis Pharmaceutical Introduction and Business Overview
7.4.3 Abraxis Pharmaceutical Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Abraxis Pharmaceutical Protein Bound Paclitaxel (Abraxane) Product Offerings
7.4.5 Abraxis Pharmaceutical Recent Development
7.5 Hengrui Medicine
7.5.1 Hengrui Medicine Company Information
7.5.2 Hengrui Medicine Introduction and Business Overview
7.5.3 Hengrui Medicine Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Hengrui Medicine Protein Bound Paclitaxel (Abraxane) Product Offerings
7.5.5 Hengrui Medicine Recent Development
7.6 Kelun Pharmaceutical
7.6.1 Kelun Pharmaceutical Company Information
7.6.2 Kelun Pharmaceutical Introduction and Business Overview
7.6.3 Kelun Pharmaceutical Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Kelun Pharmaceutical Protein Bound Paclitaxel (Abraxane) Product Offerings
7.6.5 Kelun Pharmaceutical Recent Development
7.7 BeiGene
7.7.1 BeiGene Company Information
7.7.2 BeiGene Introduction and Business Overview
7.7.3 BeiGene Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 BeiGene Protein Bound Paclitaxel (Abraxane) Product Offerings
7.7.5 BeiGene Recent Development
7.8 Yangtze River Pharm
7.8.1 Yangtze River Pharm Company Information
7.8.2 Yangtze River Pharm Introduction and Business Overview
7.8.3 Yangtze River Pharm Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Yangtze River Pharm Protein Bound Paclitaxel (Abraxane) Product Offerings
7.8.5 Yangtze River Pharm Recent Development
7.9 Hisun Pharmaceutical
7.9.1 Hisun Pharmaceutical Company Information
7.9.2 Hisun Pharmaceutical Introduction and Business Overview
7.9.3 Hisun Pharmaceutical Protein Bound Paclitaxel (Abraxane) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hisun Pharmaceutical Protein Bound Paclitaxel (Abraxane) Product Offerings
7.9.5 Hisun Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Protein Bound Paclitaxel (Abraxane) Industrial Chain
8.2 Protein Bound Paclitaxel (Abraxane) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Protein Bound Paclitaxel (Abraxane) Sales Model
8.5.2 Sales Channel
8.5.3 Protein Bound Paclitaxel (Abraxane) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Qilu Pharm
Shijiazhuang Pharmaceutical
Celgene
Abraxis Pharmaceutical
Hengrui Medicine
Kelun Pharmaceutical
BeiGene
Yangtze River Pharm
Hisun Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂